I t has been proposed t h a t testosterone-induced growth produces a d i s p r o p o r t i o n a t e increase i n trunk length. Since t h e r e i s increased adrenal androgens in CAH from e a r l y f e t a l Life which may continue i n t e r m i t t e n t l y postnatally, disproportionate grouth might be expected. Body proportions uere measured i n 27 CAH p a t i e n t s (19F, 8M; 3 late-onset) aged 4-21 yr (CA) who had been t r e a t e d ui t h hydrocortisone 15-20 mglm2lday i n infancy and childhood, and dexamethasone 0.25 -0.75 mglday i n l a t e r Life.
Bone age (BA) determined by t h e TW2 method was i n advance of CA i n a l l but one p a t i e n t . S t a t u r a l grouth was complete i n 9. Standard deviation scores (SDS) uere calculated f o r s i t t i n g height (SH) and sub-ischial leg Length (SLL). SH (SDS) and SLL (SDS) f o r CA uere -0.47 ' 1.44 (mean ' SD) and -0.49 ' 1.10 respectively; when r e l a t e d t o BA the scores uere morelnegative (-1.32 ' 1.28 and -1.1 ' 1.19, respectively). The d i f f e r e n c e between t h e scores (SH (SDS) -SLL (SDS), equivalent t o 0 i n perfect proportion) was 0.01 ' 0.95 i n d i c a t i n g normal body proportions. The exception was an untreated, late-onset g i r l uhose SDS d i f f e r e n c e was t2.1, i n d i c a t i n g disproportionate trunk growth. When s t a t u r e i s below normal i n CAH, i t i s generally proportionate. Androgen-induced disproportionate growth only a r i s e s p o s t n a t a l l y and a f t e r chronic androgen excess. CONGENITAL ADRENAL HYPERPLASIA (CAH) WITH PREDNISONE SUBSTlTUTION IS NOT GROWTH HORMONE (GH) AND IGF 1 DEPENDENT Prednisone inhibits growth more potently than hydrocortisone. Supression of GH secretlon has been discussed a s one posslble mechanism. In a retrospective study GH, IGF 1 and procollagen type I11 propeptide (P-111-NP and FAB), which correlates to growth velocity . were determined longitudinally in sera of 9 children with CAH (age: 6 to 11 ys) during a n intermittent period of prednisone substitution (4mg/ma/bld) for 6 to 24 months and a subsequent period of hydrocortisone substltution (20mg/m'/tid) for 24 months. Prednlsone treatment led to a deceleration of mean growth veloclty (0.5 to -4.7 SDS for bone age) wlthout delay of sceletal maturation resulting in a mean decrease of flnal height prediction of 5 cm. While IGF 1 (4.7 f 2.1 vs. 4.3 f 1.2 Ulml, mean f I SD) and GH (5.6 f 6.1 vs. 4.0 f 6.9 ng/ml) did nor differ durlng both perlods, P-111-NP (13.1 f 3.5 vs. 28.6 f 7.4 nglml) and FAB Levels (63 f 18 vs. 128 f 29 nglml) were reduced (p<0.001) during ~~r e d r~i s o n e substitution. During both regimens in 2 of these children the nocturnal GH secretion (above 2500 ng*min*ml-' ). stilr~ulated GH levels a f t e r Insulin-induced hypoglycaemla (above 15 ng/ml) and after GRF administration (above 25 ng/ml) were normal. Our observation glves strong evidence t h a t the impalrment of growth by hydocortlsone-equivalent doses of prednisone is not medlated by changes of GH and IGFl secretion but rather by a peripheral lnhlbitlon of GH and IGFl effects a t the tlssue level.
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URINARY EXCRETION OF TETRAHYDROALDOSTERONE IN NEW-BORNS WITH SALT-WASTING 21-HYDROXYLASE DEFICIENCY.
Tetrahydroaldosterone (3a, 5p) is excreted i n u r i n e a s lucu ronide and is the major known metabolite of aldosterone. ~s?ima--t i o n o f t h i s parameter g i v e s a valuable information on d i u r n a l aldosterone production compared t o a s i n g l e estimation,of plasma aldosterone concentration.
Urine samples c o l l e c t e d during h o s p i t a l i z a t i o n f o r s t e r o i d p r o f i l i n g from 25 untreated newborns suspected o f and proven t o have salt-wasting 21-hydroxylase deficiency (CAH) were analyzed f o r Totrahydroaldosterone 3a, 5P -glucuronide (THALDO). The c h i l d r e n were from 1 day t o 4 months old, 12 were females, 1 3 males. The females were a l l v i r i l i z e d and the boys were e i t h e r admitted t o h o s p i t a l due t o salt-wasting c r i s i s o r s i b s h i p t o c h i l d r e n with 21-hydroxylase deficiency ( 3 cases). In the lowest age group with CAH 1 day -8 days o l d , THALOO excretion was 0,2-7 ug/day $mean 1,31 + 1 , 8 ug, n=13) compared t o 4-223 ug/day (mean 77 -72 ug, n-24) i n normal newborns. In t h e CAtl-grgup 14 days-1 month the excretion was 0,8-5 ~g / d a y (mean 2,7 -1 , 3 pg, "-10) compared t o 11-29 p g (mean 20 -8 pg, n= 6) i n t h e c o n t r o l s . Two c h i l d r e n with CAH, 2 and 4 month old excreted 4 and 5 pg THALDO compared t o 2-24 p g (mean 13 + 9 p g , n=5) i n normals.
In conclusion a l l 25 c h i l d r e n with untreated salt-wasting 21-hydroxylase d e f i c i e n c had ver low aldosterone roduction i r r e s p e c t i v e o f age. In r h e normal c o n t r o l s the welfknown increased a c t i v i t y In aldosterone production during the f i r s t week of l i f e was demonstrated.
